Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (173)	11/3/1998 9:11:00 AM
From: scaram(o)uche	Respond to of 1073

"Pharmacopeia will receive approximately $60 million in research funding over the five-year term of the agreement. The potential value of the collaboration may increase significantly as Pharmacopeia will be entitled to milestone and royalty payments as compounds progress through development and commercialization." Tuesday November 3, 7:30 am Eastern Time Company Press Release SOURCE: Pharmacopeia, Inc. Schering-Plough and Pharmacopeia form New Research Collaboration to Identify and Optimize Drug Discovery Candidates ***************** Nice timing, John, for addition to the portfolio. Wish we had purchased more. The sector is hot.... and second tier prices, while moving, aren't keeping up with the news IMO. Cheers! Rick